-
MannKind Is 'Making Progress' On Its Alternative To Mylan's EpiPen, Report Says
Tuesday, August 30, 2016 - 3:50pm | 310Read More...Biopharmaceutical company MannKind Corporation (NASDAQ: MNKD) is "making progress" in developing a less costly alternative to Mylan NV (NASDAQ: MYL)'s EpiPen. According to Connecticut-based News Times, MannKind's local manufacturing facility employs around 150 people in the city and plays a key...
-
High Expectations For Adobe Earnings, Not So Much For Oracle
Sunday, March 13, 2016 - 11:10pm | 563Read More...Two software giants are expected to report their latest quarterly results this week. Wall Street analysts are looking for strong results from only one of them. A handful of other companies are expected to report earnings this week as well. Off-season quarterly reports from a couple of big tech...
-
MannKind Loses 6% Following Death Of Alfred Mann & Business Update Concerning Annual Report
Friday, February 26, 2016 - 12:29pm | 311Read More...Shares of MannKind Corporation (NASDAQ: MNKD) were trading lower by 6 percent on Friday after the company sadly announced the death of Alfred E. Mann. Mann was the founder of MannKind and served as its Chairman from 2001 until February 2016. Mann also founded and largely founded 14 companies in...
-
MannKind Issues Management Update
Monday, January 11, 2016 - 3:44pm | 220Read More...Shares of MannKind Corporation (NASDAQ: MNKD) were trading slightly higher by 1.58 percent at $0.67 mid-Monday afternoon after the company provided an update on its senior management team. MannKind has withdrawn its offer to employ Duane M. DeSisto as its new CEO. The company cited "...
-
MannKind Is Plummeting
Tuesday, January 5, 2016 - 10:19am | 172Read More...Shares of MannKind Corporation (NASDAQ: MNKD) plummeted more than 40 percent Tuesday morning after the company announced the termination of its licence and collaboration agreement with Sanofi SA (ADR) (NYSE: SNY). The prior agreement consisted of the development and commercialization of Afrezza...
-
Piper Jaffray Dishes On MannKind's Afrezza Data
Monday, May 11, 2015 - 11:52am | 601Read More...MannKind Corporation (NASDAQ: MNKD) reported first quarter 2015 results on May 7, revealing underwhelming sales and a mediocre Afrezza launch. Shares of MannKind last closed at $4.02, just above the 52-week low of $3.52. Some analysts are beginning to doubt if the company can make a comeback....
-
Shares Of Second Sight Medical Continue Showing Strength Following Wednesday's IPO
Thursday, November 20, 2014 - 11:34am | 138Read More...Shares of Second Sight Medical Products Inc (NASDAQ: EYES) surged more than 100 percent on its first day of trading on Wednesday and the buying frenzy carried over into Thursday's trading action. The company develops, manufactures and markets implantable prosthetic devices that could potentially...
-
Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments
Monday, August 11, 2014 - 4:46pm | 2480Read More...U.S. markets managed to squeeze out small gains in lighter than normal volume, as geopolitical tensions may be calming down. Russia President Vladimir Putin said that the country will coordinate with the International Red Cross to send humanitarian aid to Ukraine. Meanwhile, Palestinians and...
-
Dow Flirts With 17,000, S&P 500 Inches Closer To 2,000 In First Trading Day Of The Third Quarter
Tuesday, July 1, 2014 - 4:48pm | 2089Read More...U.S. stocks were higher as the back-end of 2014 kicked off. The Dow came within less than two points of reaching the 17,000 mark as investors and traders found plenty of positives in a better-than-expected June auto sales and an expansion in U.S. manufacturing. The S&P 500 also traded at...
-
Markets Little Changed As The Quarter Comes To An End
Monday, June 30, 2014 - 4:34pm | 2316Read More...U.S. stocks were little changed as the second quarter comes to an end. Investors and traders are likely spending the last day of the quarter the same way they did to ring in the quarter: questioning the direction of the U.S. economy and wondering what is in store in the coming quarter. One...
-
Earnings Expectations For The Week Of May 12: Wal-Mart, Deere, Cisco And More
Sunday, May 11, 2014 - 4:26pm | 870Read More...Most of the S&P 500 have already posted their first-quarter results. This week, big retailers begin to share their earnings reports. Wal-Mart (NYSE: WMT), the big daddy of retailers, steps onto the earnings stage Thursday. Macy's (NYSE: M) and J.C. Penney (NYSE: JCP) are also scheduled to...
-
Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy
Monday, March 31, 2014 - 4:37pm | 2097Read More...U.S. stocks rose in the final day of the first quarter as the Fed's boss Janet Yellen said there is still room for the central bank to further boost the economy. Yellen, speaking in Chicago today, said the scars from the Great Recession remain, and reaching our goals will take time." Yellen...
-
Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains
Friday, March 28, 2014 - 4:27pm | 1778Read More...U.S. stocks finished the week on a positive note despite a sell-off in the afternoon. One possible reason for the sell-off is that investors are adjusting their portfolios for the end of the quarter on Monday. Major indices rallied off the opening bell with the Dow Jones Industrial Average...
-
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
Saturday, May 18, 2013 - 3:54pm | 968Read More...Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who...
-
J.P. Morgan Maintains Underweight on MannKind (MNKD)
Tuesday, May 10, 2011 - 8:02am | 84Read More...J.P. Morgan is out with its report today on MannKind (NASDAQ: MNKD), maintaining Underweight. In a note to clients, J.P. Morgan writes, "We maintain our UW on MNKD following the 1Q update post close. We remain surprised the company has maintained an ~$950M EV in the face of an increasingly tenuous...
